Skip to main content

Peripheral Neuropathy

  • Reference work entry
  • First Online:
Geriatric Diseases

Abstract

Peripheral neuropathy can be defined as a syndrome characterized by muscle weakness and wasting, altered or loss of sensation and vasomotor symptoms. It is less common in the old-old (>80 years) compared to the young-old (65–79 years), 25% vs. 46%. It may affect a single nerve or nerve root (axonopathy or radiculopathy). The nerve cell body may be the primary site of involvement (neuronopathy) and the sensory or autonomic ganglia (ganglioneuropathies). There are several causes. The clinical manifestations of neuropathy depend on the type, distribution and degree of damage of the nerve(s). Diabetes and alcoholism are the most common causes of polyneuropathy in Australia. Guillain-Barre syndrome (GBS) is the third most common. GBS has a bimodal age distribution, one peak in the young and another in the older population. GBS can be divided into demyelinating and axonal forms based on pathological and electrodiagnostic findings. They are the acute inflammatory demyelinating polyradiculopathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), Miller Fisher syndrome and panautonomic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Verghese J, Biari PL, Gellido C, Schaumburg HH, Herskovitz S. Peripheral neuropathy in young-old and old-old patients. Muscle & Nerve. 2001;24:1476–1481.

    Article  CAS  Google Scholar 

  2. Hahn AF, Guillain-Barre syndrome. Lancet. 1998;352:635–41.

    Article  CAS  PubMed  Google Scholar 

  3. Hughes RAC. Peripheral neuropathy. BMJ. 2002;324(7335):466–469.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Camdessanche JP, Jousserand G, Ferraud K, Vial C, Petiot P, Honnorat J, et al. The pattern and diagnostic criteria of sensory neuropathy: a case-control study. Brain 2009;132(Pt7):1723–33. (abstract).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kuntzer T. Ganglionopathies: evolving concept and ideas on management. Rev Neurol (Paris) 2006;162(12):1268–72.

    Article  CAS  Google Scholar 

  6. Kumar N.B. Neurological aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–26.

    Article  PubMed  Google Scholar 

  7. Wynn M, Wynn A. The danger of B12 deficiency in the elderly. Nutr Health. 1998;12:215–26.

    Article  CAS  PubMed  Google Scholar 

  8. Scherer K. Neurologic manifestation of vitamin B12 deficiency. NEJM. 2003;348:2208. https://doi.org/10.1056/NEJMicm020588.

  9. Saperstein DS, Barotin, RJ. Peripheral neuropathy due to cobalamin deficiency. Current Treatment Options. Neurology. 2002;4:197–201.

    PubMed  Google Scholar 

  10. Chin RL. Neuropathology and the gastrointestinal system. http://www.neuropathy.org/site/DocServer/nutritional. GI-RussellCMD.pdf?docID=1601.

  11. Lin K, Kwan SY, Chen SY, ChenSS, Yeung KB, Chia LG, et al. Generalised neuropathy in Taiwan: an etiologic survey. Neuroepidemiology. 1993;12:257–9.

    Article  CAS  PubMed  Google Scholar 

  12. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular syndrome. Crit Care Med. 1996;24:1408–16.

    Article  CAS  PubMed  Google Scholar 

  13. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47:1223–1231.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nagaratnam N, Jamieson G, Chiu K, Ramos C. Critical illness neuropathy. Neurorehab Neural Repair. 2001;15:49–52.

    Google Scholar 

  15. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338:732–6.

    Article  CAS  PubMed  Google Scholar 

  16. Ludolph AC, Spencer PS. Toxic neuropathies and their treatment. Baillieres Clin Neurol. 1995;4(3):505–27.

    CAS  PubMed  Google Scholar 

  17. Hughes RA, Comblath DR. Guillain-Barre syndrome. Lancet. 2005;366(9497):1653–66.

    Article  CAS  PubMed  Google Scholar 

  18. Vucic S, Kierman MC, Comblath DR. Guillain-Barre syndrome: an update. J Clin Neurosci. 2009;16(6):733–41.

    Article  PubMed  Google Scholar 

  19. Newswanger DL, Warren CR. Guillain-Barre Syndrome. Am Fam Physician. 2004. http://www.aafp.org/afp/20040515/2405.html.

  20. Odaka M, Yuki N, Hiurata K. Anti-GQib IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70(1):50–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Winner SJ,Grimely EJ. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. QJM 1990;77(3):1297–1304.

    Article  CAS  PubMed  Google Scholar 

  22. DanielS, Green R. Guillain-Barre’ Syndrome. wwwfrca.co.uk/Documents/238GuillainBarreSyndrome.pdf. accessed 2 August 2016.

  23. Kuwabara S. Guillain-Barre’ syndrome: epidemiology, pathophysiology and management. Drugs. 2004;64(6): 697–610.

    Article  Google Scholar 

  24. Odaka M, Yuki N. Variants and differential diagnosis of Guillain-Barre syndrome. Expert Review Neurology. 2002;2(6):877–889.

    Article  Google Scholar 

  25. The prognosis and main prognostic indicators of Guillain-Barre’ syndrome: a multicentre prospective study of 297 patients. The Italian Guillain-Barre’ Study Group. 1996;119;(pt 6): 2053–61.

    Google Scholar 

  26. Ropper AH. Guillain-Barre syndrome. N Engl J Med 1992;328:1130–6.

    Google Scholar 

  27. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. J Neuroimunol. 1999;100(1–2):74–97.

    Article  CAS  Google Scholar 

  28. Thomas M, Allen SC Guillain-Barre’ syndrome. in elderly patients. JHK Geriatr Soc. 1995;6:11–13.

    Google Scholar 

  29. Mayo Clinic Staff. Diseases and conditions: Botulism. http://www.mayoclinic.org/diseases-conditions/botulism/basics/symptoms/con-20025875 retrieved 14 February 2015.

  30. Longina L, Donughy M. Diphtheritic polyneuropathies: A clinical study and comparison with Guillain-Barre Syndrome. J Neurol Neurosurg Psychiatry. 1999;87(4):433–438.

    Article  Google Scholar 

  31. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Pachner AR, et al. Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobio Hyg A. 1996;263(1–2):201–5.

    Google Scholar 

  32. Baraba R, Sruk A, Sragalj L, Butkovic-Soldo S, Bielen I. Electrophysiological findings in early Guillain-Barre syndrome. Acta Clin Croat. 2011;50(2):201–7.

    PubMed  Google Scholar 

  33. Kimoto K, Koga M, Odaka M, Hirata K, Takihashi M, Li J, et al. Relationship of bacterial strains to clinical syndromes of Camphylobacter associated neuropathies. Neurology. 2006;67(10):1837–43

    Article  CAS  PubMed  Google Scholar 

  34. Alshekhlee A, Hussai Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608–1613.

    Article  PubMed  Google Scholar 

  35. Sridharan GV, Tallis RC, Gautam PC. Guillain-Barre syndrome in the elderly. A retrospective comparative study. Gerontology. 1993;39(3):170–5.

    Article  CAS  PubMed  Google Scholar 

  36. Leung SS. Guillain-Barre syndrome in elderly people. J Am Geriatr Soc. 2008;56:381–382.

    Article  PubMed  Google Scholar 

  37. Franca MC, Deus-Silva L, de Castro R, Garibaldi SG, Pfeilsticker BHM, Nucci A, Marques Jr FFC. Guillain-Barre syndrome in the elderly: clinical electrophysiological therapeutic and outcome features. Arq Neuro-Pisquiatr 2005;63(3b): https://doi.org/10.1590/S0004-282x2005000500010.

  38. Yan WX, Archelos JJ, Hartung H-P, Pollard JD. Po protein is a target antigen in chronic inflammatory demyelinating polyradiculopathy. Ann Neurol 2001;50:286–292.

    Article  CAS  PubMed  Google Scholar 

  39. Shields RW Jr. Peripheral Neuropathy. Cleveland Clinic. Center for Continuing Education. http://www.clevelandclinic meded.com/medicalpubs/diseasemanagement/neurology/per accessed on 2 April 2014.

  40. Willison HJ, Winer JB. Clinical examination and investigation of neuropathies. J Neurol Neurosurg Psychiatry 2003;74:ii3–li8. https://doi.org/10.1136/nnp.74.supp_2,ii3

    Article  PubMed  PubMed Central  Google Scholar 

  41. Pan Yi. Uremic neuropathy. Emedicine.medscape.com/article1175425. accessed 25 Aust 2016.

  42. Strait S, Medcalf P. Peripheral neuropathy in older people. GM 42.November 2012. http://www.gmjournal.co.uk/Peripheral _neuropathy_in_oder_People__29143.aspx accessed on 11 November 2015.

  43. Richardson JK. Peripheral neuropathy: an often overlooked cause of falls in the elderly. Postgrad Med. 1996;99(6):161–72.

    Article  CAS  Google Scholar 

  44. Vinik AI, Stritmeyer ES, Nakave AA, Patel CV. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407–v.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sorock GS, Labiner DM. Peripheral neuromuscular dysfunction and falls in a elderly cohort. Am J Epidemiol. 1992;136:584–91.

    Article  CAS  PubMed  Google Scholar 

  46. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence predictors and consequences of peripheral sensory neuropathy in older patients. Jam Board Fam Med. 2004;17(5):309–318.

    Article  Google Scholar 

  47. Maty SC, FriedLP, Volpato S, Williamson J., Brancati FC, Blaum CS. Patterns of disability related to diabetes mellitus in older women. J Gerontol Biol Sci Med Sci. 2004;59:148–153.

    Article  Google Scholar 

  48. Richardson JK, Thies SB, De Mott TK, Ashton-Miller JA. A comparison of gait characteristics between men with or without peripheral neuropathies in standard and challenging environments. J Am Geriatr Soc. 2004;52:1532–1537.

    Article  PubMed  Google Scholar 

  49. Menz HB, Lord SR, St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic neuropathy. Arch Phys Med Rehab. 2004;85:245–252.

    Article  Google Scholar 

  50. Azidah AK, Hasniza H, Husmati LY. Peripheral neuropathy among the elderly: diabetes in a Tertiary Center Malaysia. Int J Collaborative Res Int Med Pub Health. 2014;6(3):64–72.

    Google Scholar 

  51. Vickova-Moravcova E, Bednarik J. Painful sensory neuropathies in the elderly. Scripta Medica 2009;1–5. http://www.medmuni.cz/biomedjournal/737-archive?clanek+3 accessed11 November 2015.

  52. Wlassoff V. Vitamin B12 deficiency and its neurological consequences. Neuroscience &Neurology. Brain Blogger. http://brainblogger.com/2014/07/30/vitamin-B12-deficincy-and-its-neurological-cnsequences. Accessed 11 November 2015.

  53. Sethi N, Robilotti E, Sadan Y. Neurological manifestations of vitamin B-12 deficiency. Int Sci Pub http://ispub.com/IJNW/2?1/4476 accessed 11 November 2015.

  54. George J, Twomey JA. Causes of polyneuropathies in the elderly. Age Ageing. 1986;15:247–249.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Peripheral Neuropathy. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33434-9_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33433-2

  • Online ISBN: 978-3-319-33434-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics